What is Idexx Laboratories's revenue?

Idexx Laboratories (IDXX) generated $4.4B in revenue over the trailing twelve months, up 13.1% year over year.

Is Idexx Laboratories profitable?

Idexx Laboratories reported $1.1B in net income over the trailing twelve months, a 24.6% net margin.

What are Idexx Laboratories's profit margins?

Gross margin is 62.1% and operating margin is 31.6%, with a 24.6% net margin.

What is Idexx Laboratories's earnings per share?

Idexx Laboratories's diluted EPS over the trailing twelve months is $13.59.

Where does Idexx Laboratories's income statement data come from?

Every line is extracted from Idexx Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Idexx Laboratories IDXX Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$4.45B+13.1%	$4.3B+10.4%	$4.17B+8.4%	$4.04B+6.7%	$3.93B+5.6%
Total cost of revenue	$1.69B+10.8%	$1.64B+8.3%	$1.6B+5.6%	$1.55B+3.6%	$1.52B+2.5%
Gross profit	$2.76B+14.5%	$2.66B+11.8%	$2.57B+10.2%	$2.48B+8.7%	$2.41B+7.6%
Gross margin	62.1%+0.8pp	61.8%+0.8pp	61.7%+1.0pp	61.5%+1.1pp	61.3%+1.1pp
Research and development	$257.93M+14.0%	$251.21M+14.3%	$242.1M+13.2%	$232.67M+11.9%	$226.22M+13.7%
Selling and marketing	$662.57M+11.3%	$643.55M+9.4%	$626.6M+8.0%	$613.72M+7.7%	$595.28M+4.9%
General and administrative	$432.35M-2.1%	$404.79M-8.5%	$397.32M-7.2%	$383.27M-9.9%	$441.83M+23.5%
Total operating expenses	$1.35B+7.1%	$1.3B+3.9%	$1.27B+4.2%	$1.23B+2.8%	$1.26B+13.4%
Operating income	$1.41B+22.7%	$1.36B+20.5%	$1.31B+17.5%	$1.26B+15.9%	$1.15B+2.7%
Operating margin	31.6%+2.5pp	31.6%+2.7pp	31.3%+2.4pp	31.1%+2.5pp	29.1%-0.8pp
Interest expense	$38.93M+25.7%	$38.85M+24.5%	$37.14M+12.6%	$34.18M+0.8%	$30.96M-14.9%
Income before income taxes	$1.37B+21.8%	$1.32B+19.3%	$1.27B+16.5%	$1.23B+15.6%	$1.12B+3.3%
Income tax expense	$274.31M+19.5%	$264.73M+19.3%	$246.17M+8.5%	$242.08M+11.8%	$229.47M+3.2%
Net income	$1.1B+22.4%	$1.06B+19.3%	$1.03B+18.6%	$985.66M+16.6%	$894.97M+3.3%
Net margin	24.6%+1.9pp	24.6%+1.8pp	24.7%+2.1pp	24.4%+2.1pp	22.8%-0.5pp
Diluted earnings per share	$13.59+25.6%	$13.08+22.6%	$12.61+21.7%	$12.01+19.0%	$10.82+4.8%
EBITDA	$1.55B+21.5%	$1.51B+19.6%	$1.45B+16.8%	$1.39B+15.7%	$1.28B+3.9%
EBITDA margin	35%+2.4pp	35%+2.7pp	34.7%+2.5pp	34.5%+2.7pp	32.6%-0.5pp
EBIT	$1.41B+22.7%	$1.36B+20.5%	$1.31B+17.5%	$1.26B+15.9%	$1.15B+2.7%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Idexx Laboratories.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Idexx Laboratories's revenue?: Idexx Laboratories (IDXX) generated $4.4B in revenue over the trailing twelve months, up 13.1% year over year.
Is Idexx Laboratories profitable?: Idexx Laboratories reported $1.1B in net income over the trailing twelve months, a 24.6% net margin.
What are Idexx Laboratories's profit margins?: Gross margin is 62.1% and operating margin is 31.6%, with a 24.6% net margin.
What is Idexx Laboratories's earnings per share?: Idexx Laboratories's diluted EPS over the trailing twelve months is $13.59.
Where does Idexx Laboratories's income statement data come from?: Every line is extracted from Idexx Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.